RESUMEN
Osteoclasts are the cells primarily responsible for inflammation-induced bone loss, as is particularly seen in rheumatoid arthritis. Increasing evidence suggests that osteoclasts formed under homeostatic versus inflammatory conditions may differ in phenotype. While microRNA-29-3p family members (miR-29a-3p, miR-29b-3p, miR-29c-3p) promote the function of RANKL-induced osteoclasts, the role of miR-29-3p during inflammatory TNF-α-induced osteoclastogenesis is unknown. We used bulk RNA-seq, histology, qRT-PCR, reporter assays, and western blot analysis to examine bone marrow monocytic cell cultures and tissue from male mice in which the function of miR-29-3p family members was decreased by expression of a miR-29-3p tough decoy (TuD) competitive inhibitor in the myeloid lineage (LysM-cre). We found that RANKL-treated monocytic cells expressing the miR-29-3p TuD developed a hypercytokinemia/proinflammatory gene expression profile in vitro, which is associated with macrophages. These data support the concept that miR-29-3p suppresses macrophage lineage commitment and may have anti-inflammatory effects. In correlation, when miR-29-3p activity was decreased, TNF-α-induced osteoclast formation was accentuated in an in vivo model of localized osteolysis and in a cell-autonomous manner in vitro. Further, miR-29-3p targets mouse TNF receptor 1 (TNFR1/Tnfrsf1a), an evolutionarily conserved regulatory mechanism, which likely contributes to the increased TNF-α signaling sensitivity observed in the miR-29-3p decoy cells. Whereas our previous studies demonstrated that the miR-29-3p family promotes RANKL-induced bone resorption, the present work shows that miR-29-3p dampens TNF-α-induced osteoclastogenesis, indicating that miR-29-3p has pleiotropic effects in bone homeostasis and inflammatory osteolysis. Our data supports the concept that the knockdown of miR-29-3p activity could prime myeloid cells to respond to an inflammatory challenge and potentially shift lineage commitment toward macrophage, making the miR-29-3p family a potential therapeutic target for modulating inflammatory response.
Asunto(s)
Inflamación , MicroARNs , Osteoclastos , Osteólisis , Ligando RANK , MicroARNs/genética , MicroARNs/metabolismo , Animales , Osteólisis/genética , Osteólisis/patología , Osteólisis/metabolismo , Osteoclastos/metabolismo , Osteoclastos/patología , Ratones , Ligando RANK/metabolismo , Ligando RANK/genética , Inflamación/genética , Inflamación/patología , Inflamación/metabolismo , Masculino , Macrófagos/metabolismo , Factor de Necrosis Tumoral alfa/metabolismo , Osteogénesis/genética , Ratones Endogámicos C57BL , Monocitos/metabolismoRESUMEN
Osteolytic bone lesion is a major cause of lower quality of life and poor prognosis in patients with multiple myeloma (MM), but molecular pathogenesis of the osteolytic process in MM remains elusive. Fms-like tyrosine kinase 3 ligand (FLT3L) was reported to be elevated in bone marrow (BM) and blood of patients with advanced MM who often show osteolysis. Here, we investigated a functional link of FLT3L to osteolytic process in MM. We recruited 86, 306, and 52 patients with MM, acute myeloid leukemia (AML), and acute lymphoblastic leukemia (ALL), respectively. FLT3L levels of patients with hematologic malignancies were measured in BM-derived plasma and found to be significantly higher in MM than in AML or ALL, which rarely show osteolysis. FLT3L levels were further elevated in MM patients with bone lesion compared with patients without bone lesion. In vitro cell-based assays showed that the administration of FLT3L to HEK293T, HeLa, and U2OS cells led to an increase in the DKK1 transcript level through STAT3 phosphorylation at tyrosine 705. WNT reporter assay showed that FLT3L treatment reduced WNT signaling and nuclear translocation of ß-catenin. These results collectively show that the FLT3L-STAT3-DKK1 pathway inhibits WNT signaling-mediated bone formation in MM, which can cause osteolytic bone lesion. Finally, transcriptomic profiles revealed that FLT3L and DKK1 were predominantly elevated in the hyperdiploidy subtype of MM. Taken together, FLT3L can serve as a promising biomarker for predicting osteolytic bone lesion and also a potential therapeutic target to prohibit the progression of the osteolytic process in MM with hyperdiploidy.
Asunto(s)
Mieloma Múltiple , Osteólisis , Humanos , Mieloma Múltiple/genética , Mieloma Múltiple/patología , Mieloma Múltiple/metabolismo , Osteólisis/patología , Osteólisis/genética , Osteólisis/etiología , Vía de Señalización Wnt , Masculino , Femenino , Persona de Mediana Edad , Anciano , Línea Celular Tumoral , Factor de Transcripción STAT3/metabolismo , Factor de Transcripción STAT3/genética , Estadificación de Neoplasias , Péptidos y Proteínas de Señalización Intercelular/genética , Péptidos y Proteínas de Señalización Intercelular/metabolismo , AdultoRESUMEN
Multicentric carpotarsal osteolysis syndrome (MCTO) is a rare skeletal disorder characterized by progressive osteolysis involving the carpal and tarsal bones, and often associated with nephropathy. It is caused by heterozygous mutation in the MAF bZIP transcription factor B (MAFB) gene. Heterogeneous clinical manifestation and wide spectrum of disease severity have been observed in patients with MCTO. Here, we report a case of a male patient who presented with kidney failure in childhood with progressive disabling skeletal deformity. He was diagnosed with MCTO at 31-years-old, where a de novo pathogenic heterozygous variant in NM_005461.5:c.212C>A: p.(Pro71His) of the MAFB gene was identified. While there has been little data on the long-term prognosis and life expectancy of this disease, this case report sheds light on the debilitating disease course with multiple significant morbidities of a patient with MCTO throughout his lifetime of 33 years.
Asunto(s)
Factor de Transcripción MafB , Osteólisis , Humanos , Masculino , Osteólisis/genética , Osteólisis/patología , Factor de Transcripción MafB/genética , Adulto , Mutación/genética , Huesos Tarsianos/patología , Huesos Tarsianos/anomalías , Huesos del Carpo/anomalías , Huesos del Carpo/patología , Heterocigoto , FenotipoRESUMEN
Periprosthetic osteolysis (PPO) induced by wear particles is considered the primary cause of titanium prosthesis failure and revision surgery. The specific molecular mechanisms involve titanium particles inducing multiple intracellular pathways, which impact disease prevention and the targeted therapy of PPO. Notably, N6methyladenosine (m6A) serves critical roles in epigenetic regulation, particularly in bone metabolism and inflammatory responses. Thus, the present study aimed to determine the role of RNA methylation in titanium particleinduced osteolysis. Results of reverse transcriptionquantitative PCR (RTqPCR), western blotting, ELISA and RNA dot blot assays revealed that titanium particles induced osteogenic inhibition and proinflammatory responses, accompanied by the reduced expression of methyltransferaselike (Mettl) 3, a key component of m6A methyltransferase. Specific lentiviruses vectors were employed for Mettl3 knockdown and overexpression experiments. RTqPCR, western blotting and ELISA revealed that the knockdown of Mettl3 induced osteogenic inhibition and proinflammatory responses comparable with that induced by titanium particle, while Mettl3 overexpression attenuated titanium particleinduced cellular reactions. Methylated RNA immunoprecipitationqPCR results revealed that titanium particles mediated the methylation of two inhibitory molecules, namely Smad7 and SMAD specific E3 ubiquitin protein ligase 1, via Mettl3 in bone morphogenetic protein signaling, leading to osteogenic inhibition. Furthermore, titanium particles induced activation of the nucleotide binding oligomerization domain 1 signaling pathway through methylation regulation, and the subsequent activation of the MAPK and NFκB pathways. Collectively, the results of the present study indicated that titanium particles utilized Mettl3 as an upstream regulatory molecule to induce osteogenic inhibition and inflammatory responses. Thus, the present study may provide novel insights into potential therapeutic targets for aseptic loosening in titanium prostheses.
Asunto(s)
Osteólisis , Humanos , Osteólisis/inducido químicamente , Osteólisis/genética , Titanio/toxicidad , Metilación de ARN , Epigénesis Genética , ARN/metabolismo , Metiltransferasas/genética , Metiltransferasas/metabolismoRESUMEN
BACKGROUND: Multicentric carpotarsal osteolysis (MCTO) is a rare genetic disorder characterized by the progressive loss of bone in the hands, feet, and other skeletal structures. It presents with symptoms that may resemble those of juvenile idiopathic arthritis, making diagnosis challenging for clinicians. The identification of MAF BZIP Transcription Factor B (MAFB) mutations as significant contributors to MCTO represents a major breakthrough in our understanding of the pathogenesis of this rare skeletal disorder. CASE PRESENTATION: Our objective was to present the phenotype, treatment, and outcome of a patient with a variant of MAFB-induced MCTO to broaden the range of clinical features associated with MCTO and share our clinical experience for improved diagnosis and treatment. In our case, early MRI examination of the bones and whole exome sequencing enabled an early and accurate MCTO diagnosis, and timely Denosumab administration resulted in no deterioration. CONCLUSION: This suggests that MRI examination and whole exome sequencing should be considered when MCTO is suspected, and Denosumab might be an option in the treatment of MCTO.
Asunto(s)
Osteólisis , Humanos , Osteólisis/diagnóstico por imagen , Osteólisis/genética , Denosumab , Mutación , Fenotipo , Factor de Transcripción MafB/genéticaRESUMEN
BACKGROUND: Total joint replacement for osteoarthritis is one of the most successful surgical procedures in modern medicine. However, aseptic loosening continues to be a leading cause of revision arthroplasty. The diagnosis of aseptic loosening remains a challenge as patients are often asymptomatic until the late stages. MicroRNA (miRNA) has been demonstrated to be a useful diagnostic tool and has been successfully used in the diagnosis of other diseases. We aimed to identify differentially expressed miRNA in the plasma of patients with aseptic loosening. METHODS: Adult patients undergoing revision arthroplasty for aseptic loosening and age- and gender-matched controls were recruited. Samples of bone, tissue and blood were collected, and RNA sequencing was performed in 24 patients with aseptic loosening and 26 controls. Differentially expressed miRNA in plasma was matched to differentially expressed mRNA in periprosthetic bone and tissue. Western blot was used to validate protein expression. RESULTS: Seven miRNA was differentially expressed in the plasma of patients with osteolysis (logFC >|2|, adj-P < 0.05). Three thousand six hundred and eighty mRNA genes in bone and 427 mRNA genes in tissue samples of osteolysis patients were differentially expressed (logFC >|2|, adj-P < 0.05). Gene enrichment analysis and pathway analysis revealed two miRNA (miR-1246 and miR-6089) had multiple gene targets in the Wnt signalling pathway in the local bone and tissues which regulate bone metabolism. CONCLUSION: These results suggest that aseptic loosening may be regulated by miR-1246 and miR-6089 via the Wnt signalling pathway.
Asunto(s)
Artroplastia de Reemplazo de Cadera , MicroARNs , Osteólisis , Adulto , Humanos , Artroplastia de Reemplazo de Cadera/efectos adversos , MicroARNs/genética , Osteólisis/genética , Falla de Prótesis , Reoperación/efectos adversos , ARN Mensajero/genéticaRESUMEN
Bone metastasis is common in breast cancer and more effective therapies are required, however, its molecular mechanism is poorly understood. Additionally, the role of the m6A reader YTHDF1 in bone metastasis of breast cancer has not been reported. Here, we reveal that the increased expression of YTHDF1 is clinically correlated with breast cancer bone metastases. YTHDF1 promotes migration, invasion, and osteoblast adhesion and induces osteoclast differentiation of cancer cells in vitro and vivo. Mechanically, RNA-seq, MeRIP-seq and RIP-seq analysis, and molecular biology experiments demonstrate that YTHDF1 translationally enhances EZH2 and CDH11 expression by reading m6A-enriched sites of their transcripts. Moreover, adeno-associated virus (AAV) was used to deliver shYTHDF1 (shYTHDF1-AAV) in intratibial injection models, eliciting a significant suppressive effect on breast cancer bone metastatic formation and osteolytic destruction. Overall, we uncovered that YTHDF1 promotes osteolytic bone metastases of breast cancer by inducing EZH2 and CDH11 translation.
Asunto(s)
Neoplasias Óseas , Neoplasias de la Mama , Cadherinas , Proteína Potenciadora del Homólogo Zeste 2 , Osteólisis , Proteínas de Unión al ARN , Animales , Femenino , Humanos , Ratones , Neoplasias Óseas/secundario , Neoplasias Óseas/genética , Neoplasias Óseas/metabolismo , Neoplasias de la Mama/patología , Neoplasias de la Mama/genética , Neoplasias de la Mama/metabolismo , Cadherinas/metabolismo , Cadherinas/genética , Diferenciación Celular , Línea Celular Tumoral , Movimiento Celular , Proteína Potenciadora del Homólogo Zeste 2/metabolismo , Proteína Potenciadora del Homólogo Zeste 2/genética , Regulación Neoplásica de la Expresión Génica , Osteoclastos/metabolismo , Osteoclastos/patología , Osteólisis/genética , Proteínas de Unión al ARN/genética , Proteínas de Unión al ARN/metabolismoRESUMEN
Chronic periodontitis and apical periodontitis are infectious diseases characterized by the inflammatory destruction of teeth-supporting tissues. The clinical presentation of these diseases is the result of the interaction between the infecting microorganisms and the host's defense mechanisms, constituting the host/pathogen barrier. Genetic variations are associated with differential susceptibility profiles, modulating simultaneously the patterns of infection and immune response. Therefore, we investigated the association of selected genetic variations with phenotypes of resistance or susceptibility to periodontal and periapical inflammatory bone resorption, as well as with changes in the sub gingival microbial profile and host's response biomarkers. The polymorphism rs4794067 (gene TBX21) proved significantly associated with increased risk to suffer periodontitis. Polymorphic allele-carriers demonstrated increased expression of T-bet. IFN-γ expression and bacterial load proved unaltered by genotype differences. The mutation rs333 (a.k.a. CCR5Δ32, in gene CCR5) demonstrated a protective effect against chronic periodontitis. Heterozygous subjects exhibited decreased TNF-α expression. The genetic mutation was unrelated to changes in the bacterial load of putative periodontal pathogens. The polymorphisms rs2521634 (gene NPY), rs10010758 (gene TBC1D), rs6667202 (gene IL10), and rs10043775 (gene TBXO38) proved associated with significant changes in the composition of the subgingival biofilm in chronic periodontitis patients. For apical periodontitis we employed an unbiased biomarker screening strategy based in 2D diferential electrophoresis in tandem with mass spectrometry. Among the biomarkers that proved significantly modulated, we discover a substantial upregulation of HSP27 and SERPINB1. Both proteins were preferentially localized in the cytoplasm of epithelial cells in the epithelium lining the cystic cavity and the epithelial chords of epithelized granulomas. Additionally, SERPINB1 was expressed in infiltrating polymorph nuclear neutrophils. The expression of HSP27 and SERPINB1 demonstrated a negative correlation with acute inflammation biomarkers. Overall, these genes and protein biomarkers may be promissory targets to predict the risk profile for periodontal and periapical inflammatory bone resorption.(AU)
A periodontite crônica e a periodontite apical são doenças infecciosas caraterizadas pela destruição inflamatória dos tecidos de suporte dentários. O fenótipo clínico de ambas as doenças é o resultado da interação entre os microrganismos infectantes e os mecanismos de defesa do hospedeiro (barreira hospedeiro/patógeno). Ainda, variações genéticas podem conferir níveis diferenciais de susceptibilidade a tais doenças, teoricamente modulando tanto os padrões de infecção como de resposta do hospedeiro. Neste contexto, investigamos a associação de variações genéticas selecionadas com fenótipos de resistência e susceptibilidade a lesões osteolíticas periodontais e periapicais, assim como possíveis associações com mudanças no perfil microbiológico sub gengival e em marcadores de resposta do hospedeiro. O polimorfismo rs4794067 (no gene TBX21) demonstrou uma associação significativa com risco aumentado de sofrer periodontite crônica. Os portadores do alelo polimórfico apresentaram uma expressão significativamente aumentada de Tbet. No entanto, a expressão de IFN-γ e a carga bacteriana mostraram-se independentes do perfil genético para rs4794067. O polimorfismo rs333 (também conhecido como CCR5Δ32, no gene CCR5) demonstrou um efeito protetor para periodontite crônica. Os pacientes heterozigotos exibiram níveis de expressão significativamente diminuídos de TNF-α, porém, os níveis bacterianos mostraram-se independentes do perfil genético para rs333. Os polimorfismos rs2521634 (no gene NPY), rs10010758 (no gene TBC1D), rs6667202 (no gene IL10) e rs10043775 (no gene TBXO38) demostraram uma associação significativa com mudanças no perfil microbiológico sub gengival em pacientes com periodontite crônica. No caso da periodontite apical, escolhemos uma metodologia de seleção de marcadores baseada no uso consecutivo de eletroforeses diferencial bidimensional e espectrometria de massa. Dentre os marcadores que apresentaram uma modulação significativa, as lesões de periodontite apical demostraram uma supraregulação de HSP27 e SERPINB1. Ambas as proteínas foram preferencialmente imunomarcadas nas ilhas epiteliais dentro das lesões. A expressão de HSP27 e SERPINB1 apresentou uma correlação negativa com os marcadores de inflamação aguda. Assim sendo, estes genes e biomarcadores proteicos mostram-se como alvos promissórios para a determinação do perfil de risco de lesões osteolíticas periodontais e periapicais.(AU)
Asunto(s)
Humanos , Periodontitis Agresiva/genética , Osteólisis/genética , Periodontitis Periapical/genética , Polimorfismo Genético , Estudios de Asociación Genética , Marcadores Genéticos , Predisposición Genética a la Enfermedad , Genotipo , Factores de RiesgoRESUMEN
Presentamos el caso de una familia portadora de una rara enfermedad de herencia autosómica dominante llamada osteolisis familiar expansiva. Sus rasgos mas característicos son lesiones osteolíticas de huesos largos, con dolor, deformidad, y tendencia a la fractura patológica, pérdida auditiva y, coma rasgo diferencial de otras enfermedades, reabsorciones dentarias múltiples a nivel radicular siguiendo un patrón de reabsorción característico. La fosfatasa alcalina y la deoxipiridinolina estan elevadas en grado variable. Otros indicadores bioquímicos son normales. Los tratamientos en base a alendronato no han dado resultado a largo plazo